ArticleScientific reports2025

Attribute based cross classification analyses from the BRIGHTEN study reveal that therapeutic responsiveness to erythropoiesis stimulating agents predicts cardiorenal prognosis in renal anemia.

Hiroshi Kataoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.